FDA ‘Priority Voucher’ Program Faces Congressional Review

(MedPage Today) — Two members of Congress have launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of “priority vouchers” to speed drug approvals, suggesting that the voucher program “could undermine public trust…